Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperkalemia of non-renal origin in a hemodialysis patient.
Rodríguez P, Mérida E, Hernández E, Milla M, Praga M. Rodríguez P, et al. Among authors: milla m. Nefrologia (Engl Ed). 2018 Jan-Feb;38(1):96-97. doi: 10.1016/j.nefro.2017.01.005. Nefrologia (Engl Ed). 2018. PMID: 29325672 Free article. English, Spanish. No abstract available.
Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.
Abad S, Vega A, Hernández E, Mérida E, de Sequera P, Albalate M, Macías N, Milla M, López-Gómez JM. Abad S, et al. Among authors: milla m. Am J Nephrol. 2017;45(3):267-272. doi: 10.1159/000454819. Epub 2017 Jan 7. Am J Nephrol. 2017. PMID: 28166520
Incidence of Hypersensitivity Reactions During Hemodialysis.
Esteras R, Martín-Navarro J, Ledesma G, Fernández-Prado R, Carreño G, Cintra M, Cidraque I, Sanz I, Tarragón B, Alexandru S, Milla M, Astudillo E, Sánchez E, Mas S, Tejeiro RD, Ortiz A, Sánchez R, González-Parra E. Esteras R, et al. Among authors: milla m. Kidney Blood Press Res. 2018;43(5):1472-1478. doi: 10.1159/000493662. Epub 2018 Sep 20. Kidney Blood Press Res. 2018. PMID: 30235456 Free article.
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.
Nencini F, Vultaggio A, Pratesi S, Cammelli D, Milla M, Fiori G, Bagnoli S, Prignano F, Romagnani S, Maggi E, Matucci A. Nencini F, et al. Among authors: milla m. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2065-2072.e2. doi: 10.1016/j.jaip.2018.04.007. Epub 2018 Apr 13. J Allergy Clin Immunol Pract. 2018. PMID: 29660428
163 results